Anesthesiology最新文献

Background: Retrospective studies suggest that pulse oximetry overestimates saturation in children from races that may be associated with darker skin tone. Near-infrared spectroscopy (NIRS) relies on similar optical technology, but less is known about the effect of skin tone on NIRS. This study aimed to quantify the effect of skin tone on NIRS performance.

Methods: Consecutive patients under 21 yr old undergoing cardiac catheterization were enrolled (N = 110). Skin tone was measured using spectrophotometry. Regional oxygen saturation was recorded from a Medtronic (USA) INVOS 5100C NIRS device placed on the forehead and was compared to the mixed venous saturation. Multivariable linear regressions were used to determine the effect of skin tone measured by individual typology angle (ITA).

Results: Mean bias was larger for patients with darker skin in ITA categories 5 and 6 at -12.8% compared to ITA categories 3 and 4 at -2.5% with a difference of 10.3% (95% CI, 4.4 to 16.3; P < 0.001) and ITA categories 1 and 2 at 0.3% with a difference of 13.1% (95% CI, 7.5 to 18.7; P < 0.001). ITA was associated with NIRS bias in multivariable regression analysis (coefficient, 0.173; P < 0.001).

Conclusions: Darker skin tone is associated with worse NIRS performance and lower NIRS values compared to mixed venous saturation for the INVOS 5100C system. This may lead to differences in care and contribute to inequities in outcomes. Better validation guidelines are needed to ensure equity in performance across varying skin tones.

Mixtures of local anesthetics and adjuvants or mixtures of different local anesthetics are frequently used in regional anesthesia to accelerate the speed of onset and increase the effect and the length of action. Recent in vitro evidence revealed extensive crystallization in mixtures of local anesthetics or local anesthetic-adjuvant mixtures, including those previously deemed "safe"-like lidocaine plus sodium bicarbonate. Several guidelines recommend the use of local anesthetic-adjuvant or mixtures of local anesthetics. In this narrative review, the authors examine the chemical, pharmacologic, and clinical implications of local anesthetic mixture use, illustrate data on efficacy, and highlight critical limitations, including the risk of particle formation, lack of pharmacologic rationale, and unclear propensity for systemic toxicity. Moreover, the authors map out a practical risk versus benefit relationship with recommendations. In light of the unclear safety profile and equivocal clinical benefit of certain mixtures of local anesthetics and local anesthetic-adjuvant mixtures, the authors caution against the routine use of some mixtures at this point, especially for neuraxial techniques.

Background: This within-subject, double-blind, randomized, placebo-controlled study aimed to determine the acute analgesic and drug effects, and risk for extramedical use, of synthetic delta-9-tetrahydrocannabinol and hydromorphone, alone and in combination, in individuals with knee osteoarthritis (KOA).

Methods: Participants (N=21; 57% women; Mean age=63.4±6.4) with KOA received oral combinations of placebo, hydromorphone (2 mg), and dronabinol (10 mg): (1, initial session) hydromorphone+placebo, (remaining sessions randomized) (2) placebo+placebo, (3) dronabinol+placebo, and (4) hydromorphone+dronabinol. Clinical and experimentally induced pain (quantitative sensory testing; QST), physical and cognitive function, subjective drug ratings, and adverse events (AEs) were evaluated at baseline and 60-, 120-, 180-, 240-minutes post-dosing.

Results: Primary Outcomes: Hydromorphone produced greater pressure pain threshold analgesia than dronabinol, p=0.029, ηp 2 =0.074; greater capsaicin (p=0.045, ηp 2 =0.062) and non-capsaicin (p=0.017, ηp 2 =0.087) sensitized mechanical temporal summation analgesia than placebo. There were no significant drug-related differences for clinical pain severity ηp 2 =0.011, thermal threshold ηp 2 =-0.025 or tolerance ηp 2 =-0.008, temporal summation ηp 2 =0.009, cold pressor ηp 2 =0.056, conditioned pain modulation ηp 2 =0.038, capsaicin-induced thermal threshold ηp 2 =-0.030, central sensitization ηp 2 =0.006, general pain sensitivity ηp 2 =0.021, or physical functioning (2-minute walking distance ηp 2 =0.028, Timed Up and Go ηp 2 =-0.027, total stair climb time ηp 2 =-0.005); all ps>.05. Secondary Outcomes : Hydromorphone impaired working memory accuracy compared to all conditions and produced greater Good Effects than placebo, ps≤.005; Hydromorphone+dronabinol impaired working memory reaction time and produced greater High ratings compared to placebo, greater Drug Effects than placebo and hydromorphone, and higher Nausea than hydromorphone, ps<.05; and Dronabinol had greater High ratings than hydromorphone, p=0.001. There were no significant drug-related differences for fine motor movement, Bad Effects, drug liking, or AE occurrence or severity (ps>.05).

Conclusions: Opioid and cannabinoid medications failed to produce robust analgesia in experimentally induced pain among patients with KOA. In contrast to preclinical studies, there was no evidence of synergistic analgesic effects by combining hydromorphone and dronabinol.

Background: Myocardial injury after hip fracture surgery is common and associated with increased mortality. Acute pain is an important risk factor, but whether peripheral nerve block (PNB) could reduce postoperative myocardial injury remains unclear. This study aimed to evaluate the association between single-injection PNB, administered as an adjunct to general or neuraxial anesthesia, and postoperative myocardial injury in high-risk cardiac older adults undergoing hip fracture surgery.

Methods: In this retrospective cohort study, patients aged ≥65 years who underwent hip fracture surgery under general or neuraxial anesthesia between 2012 and 2023 were included. Based on medical records, patients who received a single-injection PNB as an adjunct were assigned to the PNB group; those who did not were assigned to the non-PNB group. The primary outcome was postoperative myocardial injury, defined as any postoperative cardiac troponin measurement exceeding the 99th percentile upper reference limit during the index hospitalization. Confounding effects were adjusted using inverse probability of treatment weighting based on 27 baseline and intraoperative variables. A weighted logistic regression model was used to estimate odds ratio for PNB versus non-PNB groups. Missing data (24.3% of cases) were imputed using multiple imputation.

Results: Data from 1,467 patients were included in the final analysis. Postoperative myocardial injury occurred in 12.0% (96/798) of patients in the PNB group and 21.5% (144/669) in the non-PNB group. The weighted logistic regression analysis showed that single-injection PNB was associated with a significantly lower odds of postoperative myocardial injury (adjusted odds ratio, 0.60; 95% confidence interval, 0.44-0.82; P=0.002).

Conclusions: Single-injection PNB as an adjunct to general or neuraxial anesthesia was associated with a reduced risk of postoperative myocardial injury in high-risk cardiac older adults undergoing hip fracture surgery, possibly through mitigating the link between pain and myocardial injury. Further prospective trials are needed to validate these findings.